Reuters Total Health

Reuters Total Health


Ambry Genetics is a proud sponsor of Reuters Total Health 2025, where we'll present on scaling high risk cancer risk identification across health systems.

Please Join Us for a Symposium

From Missed Risk to Measurable Impact: Scaling Cancer Risk Identification Across the Health System

Wednesday, October 29 8:00am

Radisson Blu Aqua Hotel 221 North Columbus Drive, Chicago, IL 60601 US

• Advance from reactive to proactive care with accessible, system-wide high-risk patient identification

• Standardize guideline-based risk assessments for hereditary cancer testing and breast cancer risk to enable more equitable access to early diagnosis and prevention

• Discuss real-world barriers and strategies for scaling high-risk cancer identification programs

Invitation Only

We're still working on it

No registered posters or presentations yet.

Get in Touch With Us While You are Here

Set up a Meeting

Our Blog

Read our blog on why Ambry is using evidence-based quality testing.

Read More

Search Results

Start your search...